Analysts/Institutional Investor Meet/Con. Call Updates4 Nov 2026 · 18:47
Apollo Hospitals Enterprise Limited has informed the Exchange about Presentation
Markets / Nifty 50 / Healthcare
Price
Daily closing prices, adjusted for bonuses and splits
Returns against the Nifty 50
| Return | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| APOLLOHOSP | +5.7% | +7.7% | −3.5% | +10.8% | +10.1% | +66.9% | +93.7% |
| Nifty 50 | +5.6% | +6.2% | −2.7% | −1.5% | −6.4% | +24.6% | +33.7% |
Price returns, without dividends. Source: NSE end-of-day data.
Check-up
Where APOLLOHOSP sits against the Nifty 50 and its industry. Facts, not advice.
Price return
+10.10%
Over 1 year. The Nifty 50 returned −6.40%, so APOLLOHOSP beat it by 16.5 percentage points.
Valuation (PE)
55.1
Price is 55.1 times the last four quarters' earnings per share, higher than the Nifty 50's PE of 19.8 and the 4 industry peers' median of 40.0.
Growth
+20.8%
Revenue in Q2 FY27 compared with the same quarter a year earlier. Net profit changed +32.0%.
Profitability (ROE)
21.1%
Profit over the last four quarters as a share of shareholders' equity. Net margin is 8.1%.
Debt
0.53×
Borrowings are 0.53 times shareholders' equity (latest balance sheet, 30 Sep 2026).
Volatility
1.53×
Daily price moves over the last year were 1.53 times as large as the Nifty 50's (annualised volatility 21.1%).
What the latest numbers show
Calculated by stockER from the company's filings and NSE data.
Positives 5
- Revenue up 20.8% from a year ago₹7,615 cr in Q2 FY27, against ₹6,304 cr in Q2 FY26.
- Net profit up 33.5% from a year ago₹660 cr in Q2 FY27, against ₹494 cr in Q2 FY26.
- Net margin widened to 8.7%From 7.8% in Q2 FY26.
- Operating cash flow of ₹2,856 crCash generated by the business in the year to 31 Mar 2026.
- Mutual fund holding up 0.71 points in a year17.19% on 30 Sep 2026, from 16.48%.
Watch points 2
- Borrowings rose 4.7% in a year₹5,595 cr on 30 Sep 2026, against ₹5,341 cr a year earlier.
- Foreign institutional holding down 1.02 points in a year43.18% on 30 Sep 2026, from 44.20%.
Financials
Consolidated results as filed with NSE. ₹ crore unless stated.
Revenue
Net profit
EPS (₹)
| ₹ crore | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 | 7,615 |
| Other income | 64 | 61 | 40 | 55 | 53 | 44 | 49 | 45 |
| Total expenses | 5,060 | 5,148 | 5,313 | 5,690 | 5,844 | 5,938 | 6,307 | 6,768 |
| EBITDA | 825 | 831 | 892 | 996 | 999 | 1,055 | 1,141 | 1,236 |
| Depreciation | 185 | 211 | 215 | 218 | 219 | 224 | 235 | 230 |
| Finance cost | 110 | 115 | 108 | 110 | 113 | 119 | 120 | 114 |
| PBIT | 641 | 620 | 677 | 778 | 780 | 830 | 906 | 1,005 |
| Profit before tax | 531 | 505 | 569 | 668 | 667 | 711 | 785 | 891 |
| Tax | 157 | 101 | 142 | 181 | 166 | 170 | 188 | 245 |
| Net profit | 379 | 414 | 441 | 494 | 516 | 551 | 610 | 660 |
| EPS (₹) | 25.89 | 27.10 | 30.10 | 33.19 | 34.94 | 36.82 | 40.39 | 43.82 |
| ₹ crore | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue from operations | 16,612 | 19,059 | 21,794 | 25,228 |
| Other income | 90 | 106 | 200 | 192 |
| Total expenses | 15,559 | 17,805 | 19,988 | 22,785 |
| EBITDA | 2,140 | 2,499 | 3,222 | 3,942 |
| Depreciation | 615 | 687 | 758 | 876 |
| Finance cost | 381 | 449 | 458 | 450 |
| PBIT | 1,525 | 1,812 | 2,465 | 3,066 |
| Profit before tax | 1,144 | 1,362 | 2,006 | 2,616 |
| Tax | 256 | 446 | 534 | 658 |
| Net profit | 845 | 935 | 1,505 | 2,003 |
| ₹ crore | MAR 2024 | SEP 2024 | MAR 2025 | SEP 2025 | MAR 2026 | SEP 2026 |
|---|---|---|---|---|---|---|
| Total assets | 16,753 | 19,548 | 20,657 | 21,950 | 22,197 | 24,222 |
| Current assets | 5,280 | 7,338 | 7,029 | 8,023 | 6,900 | 8,182 |
| Inventories | 460 | 448 | 481 | 505 | 542 | 623 |
| Cash and equivalents | 506 | 1,435 | 578 | 488 | 811 | 587 |
| Total liabilities | 9,433 | 11,633 | 12,004 | 12,397 | 12,222 | 13,065 |
| Current liabilities | 4,664 | 5,001 | 4,579 | 4,764 | 6,481 | 6,920 |
| Borrowings | 3,162 | 4,848 | 5,275 | 5,341 | 5,658 | 5,595 |
| Shareholders' equity | 7,320 | 7,915 | 8,653 | 9,553 | 9,974 | 11,157 |
| Equity attributable to owners | 6,935 | 7,501 | 8,212 | 9,093 | 9,480 | 10,604 |
Balance sheets are filed every half year (September and March).
| ₹ crore | 6M to SEP 2022 | 12M to MAR 2025 | 6M to SEP 2025 | 12M to MAR 2026 | 6M to SEP 2026 |
|---|---|---|---|---|---|
| From operations | 993 | 2,136 | 1,325 | 2,856 | 1,493 |
| From investing | −560 | −3,381 | −1,070 | −2,148 | −1,414 |
| From financing | −455 | 1,317 | −345 | −478 | −303 |
| Capital expenditure | 759 | 1,713 | 706 | 1,962 | 1,200 |
| Free cash flow | 235 | 424 | 619 | 894 | 293 |
Cash flow statements are filed every half year; figures are for the period shown.
EBITDA here is profit before tax plus finance cost and depreciation. Annual figures add up the four quarters of each financial year. Source: company filings on NSE (XBRL).
Peers
Healthcare companies in the Nifty 50.
| Company | Price | Market cap | PE | PB | ROE | Div. yield | 1Y return |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd.APOLLOHOSP | ₹8,599.50 | ₹1.24 lakh cr | 55.1 | 11.66 | 21.1% | 0.23% | +10.1% |
| Sun Pharmaceutical Industries Ltd.SUNPHARMA | ₹1,773.40 | ₹4.25 lakh cr | 38.8 | 4.77 | 12.3% | 0.90% | +4.9% |
| Dr. Reddy's Laboratories Ltd.DRREDDY | ₹1,374.00 | ₹1.15 lakh cr | 41.0 | 2.96 | 7.2% | 0.58% | +14.5% |
| Cipla Ltd.CIPLA | ₹1,402.00 | ₹1.13 lakh cr | 39.1 | 3.20 | 8.2% | 0.93% | −6.7% |
| Max Healthcare Institute Ltd.MAXHEALTH | ₹927.15 | ₹90,240 cr | 65.4 | 7.96 | 12.2% | 0.22% | −18.6% |
Price comparison
Change in price from the start of the period
APOLLOHOSPNifty 50SUNPHARMADRREDDY
Events
Dividends, bonuses and splits from NSE's corporate actions.
Dividend paid in 5 of the last 5 calendar years (2022–2026)Over the last 12 months: ₹20.00 per share (adjusted for bonuses and splits), a yield of 0.23% at today's price.
Past dividends
Dividend
Dividend - Rs 10 Per ShPer share
₹10.00Ex-date
14 Aug 2026
Dividend - Rs 10 Per ShPer share
₹10.00Ex-date
14 Aug 2026
Interim dividend
Interim Dividend - Rs 10 Per ShPer share
₹10.00Ex-date
16 Feb 2026
Interim Dividend - Rs 10 Per ShPer share
₹10.00Ex-date
16 Feb 2026
Dividend
Dividend - Rs 10 Per SharePer share
₹10.00Ex-date
19 Aug 2025
Dividend - Rs 10 Per SharePer share
₹10.00Ex-date
19 Aug 2025
Interim dividend
Interim Dividend - Rs 9 Per SharePer share
₹9.00Ex-date
14 Feb 2025
Interim Dividend - Rs 9 Per SharePer share
₹9.00Ex-date
14 Feb 2025
Dividend
Annual General Meeting/Dividend - Rs 10 Per SharePer share
₹10.00Ex-date
16 Aug 2024
Annual General Meeting/Dividend - Rs 10 Per SharePer share
₹10.00Ex-date
16 Aug 2024
Interim dividend
Interim Dividend - Rs 6 Per SharePer share
₹6.00Ex-date
20 Feb 2024
Interim Dividend - Rs 6 Per SharePer share
₹6.00Ex-date
20 Feb 2024
Dividend
Annual General Meeting/Dividend - Rs 9 Per SharePer share
₹9.00Ex-date
18 Aug 2023
Annual General Meeting/Dividend - Rs 9 Per SharePer share
₹9.00Ex-date
18 Aug 2023
Interim dividend
Interim Dividend - Rs 6 Per SharePer share
₹6.00Ex-date
24 Feb 2023
Interim Dividend - Rs 6 Per SharePer share
₹6.00Ex-date
24 Feb 2023
Filings and updates
The company's own announcements to NSE: results, dividends, presentations and board decisions.
Annual report 2025–26Open (PDF / ZIP)
Annual report 2025–26Open (PDF / ZIP)
Annual report 2024–25Open (PDF / ZIP)
Annual report 2023–24Open (PDF / ZIP)
Annual report 2021–22Open (PDF / ZIP)
Press Release4 Nov 2026 · 18:11
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Apollo Hospitals Q2FY27 Financial Results".
Outcome of Board Meeting4 Nov 2026 · 17:49
Apollo Hospitals Enterprise Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Analysts/Institutional Investor Meet/Con. Call Updates15 Oct 2026 · 17:16
Apollo Hospitals Enterprise Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates19 Aug 2026 · 18:00
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates13 Aug 2026 · 18:40
Apollo Hospitals Enterprise Limited has informed the Exchange about Link of Recording
Investor Presentation12 Aug 2026 · 21:38
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation
Press Release12 Aug 2026 · 20:03
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results".
Outcome of Board Meeting12 Aug 2026 · 19:52
Apollo Hospitals Enterprise Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Disclosure under SEBI Takeover Regulations16 Jun 2026 · 18:39
Preetha Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Resignation30 May 2026 · 15:11
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Resignation of Mr DINESH MADHAVAN as Other of the company w.e.f. May 30, 2026.
Press Release20 May 2026 · 19:47
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated May 20, 2026, titled "Apollo Cradle and Fertility and Cloudnine combine to create one of India s largest integrated Maternity and Fertility care Platforms.".
Frequently asked questions
What is the share price of Apollo Hospitals Enterprise Ltd. (APOLLOHOSP)?
APOLLOHOSP closed at ₹8,599.50 on NSE on 4 Nov 2026, +1.89% on the day. stockER shows end-of-day prices, updated after the market closes.
What is the market cap of APOLLOHOSP?
₹1.24 lakh cr, based on 14.38 crore shares and the latest closing price. That makes it #44 by size in the Nifty 50.
What are the PE and PB ratios of APOLLOHOSP?
PE 55.15 on earnings per share of ₹155.94 over the last four quarters; PB 11.66 on the latest reported equity.
What is the 52-week high and low of APOLLOHOSP?
High ₹9,070.50 on 23 Sep 2026, low ₹6,696.50 on 23 Jan 2026 (adjusted for bonuses and splits).
What is the dividend yield of APOLLOHOSP?
0.23%: dividends of ₹20.00 per share with ex-dates in the last 12 months, divided by the latest price.
What return has APOLLOHOSP given?
1 year +10.1%, 3 years +66.9%, 5 years +93.7% (price only, dividends not included).
Which sector is APOLLOHOSP in?
NSE classifies Apollo Hospitals Enterprise Ltd. under Healthcare. Other Nifty 50 companies in it: CIPLA, DRREDDY, MAXHEALTH, SUNPHARMA.
Who owns APOLLOHOSP?
On 30 Sep 2026, promoters held 28.02% and the public 71.98%.
How can I buy APOLLOHOSP shares?
Through a SEBI-registered stockbroker with a demat and trading account. stockER is an information site only: it doesn't sell shares or recommend buying or selling any of them.